Evonik stock: results due November 3, 2026, slightly lower pre-market
Published on 10/28/2026 at 07:45 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSReporting calendar and market indication
- Evonik has scheduled its third-quarter report for November 3, 2026.
- Evonik develops and produces specialty chemicals for industrial, pharmaceutical and biotech customers.
- Evonik stock trades pre-market at EUR 21.19 at 7:42 a.m. CET at Lang & Schwarz on October 28, 2026, 0.61 percent below the Xetra close of October 27, 2026.
Evonik has scheduled its third-quarter 2026 report for November 3, 2026, according to the company’s investor-relations calendar. Evonik stock trades pre-market at EUR 21.19 at 7:42 a.m. CET at Lang & Schwarz on October 28, 2026, 0.61 percent below the Xetra close of October 27, 2026 (EUR 21.32).
Reporting date ahead
The company’s published calendar identifies the third-quarter 2026 report as the next scheduled reporting event, with the release date set for November 3, 2026. The calendar also lists subsequent quarterly reporting dates for March 4, May 4 and August 4, 2027. These dates are provided by Evonik’s investor-relations page.
Before the Xetra open
The pre-market indication is EUR 0.13 lower on the session. The bid is EUR 21.16 and the ask is EUR 21.22. The further course from the Xetra open at 9:00 a.m. CET/CEST is shown by the continuously updated real-time quote of Evonik stock.
Evonik’s business and calendar
Evonik develops and produces specialty chemicals for industrial, pharmaceutical and biotech customers. Its investor-relations calendar places the third-quarter report on November 3, 2026. Market context: Market report DAX.
